July 21, 2014—The Health Resources and Services Administration published an “interpretive” rule this morning on the statutory exclusion on 340B pricing on orphan drugs for critical access hospitals, sole community hospitals, rural referral centers, and free-standing cancer hospitals.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)